John H. Tucker - Jan 31, 2022 Form 4 Insider Report for scPharmaceuticals Inc. (SCPH)

Role
President and CEO, Director
Signature
/s/ John H. Tucker
Stock symbol
SCPH
Transactions as of
Jan 31, 2022
Transactions value $
$0
Form type
4
Date filed
2/1/2022, 04:21 PM
Previous filing
Dec 6, 2021
Next filing
Oct 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCPH Stock Option (Right to Buy) Award $0 +249K $0.00 249K Jan 31, 2022 Common Stock 249K $4.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares vest over a four-year period, at a rate of 25% on the first anniversary of the grant date, with the remaining option shares vesting in 36 equal monthly installments thereafter, such that the option shares are fully vested on the fourth anniversary of the grant date.